ImmuPharma PLC Appoints Head of Investor Relations

29th February 2012 - 7:00 am

ImmuPharma PLC (AIM: IMM), the specialist drug development company, is pleased to announce that it has appointed Lisa Baderoon as Head of Investor Relations.

Share this article

Leave a comment